SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-04-034397
Filing Date
2004-11-09
Accepted
2004-11-08 20:09:45
Documents
1
Group Members
CITADEL DERIVATIVES GROUP LLCCITADEL EQUITY FUND LTD.CITADEL INVESTMENT GROUP, L.L.C.CITADEL KENSINGTON GLOBAL STRATEGIES FUND LTD.CITADEL TRADING GROUP L.L.C.CITADEL WELLINGTON PARTNERS L.P.CITADEL WELLINGTON PARTNERS L.P. SEGLB PARTNERS, L.P.KENNETH GRI

Document Format Files

Seq Description Document Type Size
1 SC 13G a04-13056_1sc13g.htm SC 13G 320235
  Complete submission text file 0001104659-04-034397.txt   322744
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Subject) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-10728 | Film No.: 041127228
SIC: 2834 Pharmaceutical Preparations

Mailing Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60606 3123952100
CITADEL L P (Filed by) CIK: 0001027745 (see all company filings)

IRS No.: 364111741 | State of Incorp.: IL | Fiscal Year End: 1231